Experts say that a “fully approved” designation for the vaccines could have sweeping effects. Broader vaccination mandates, inclusion for new age groups, and reassurance for those hesitant to take a vaccine without the designation. As calls for approval grow louder and more urgent, the Food and Drug Administration is yet to give its blessing. What’s happening inside the FDA as they work toward this milestone?
Guest: Sarah Owermohle, health care reporter at Politico
Host:
Lizzie O’Leary
Hosted on Acast. See acast.com/privacy for more information.
